Headline
The latest stories from AHA Today.
The monoclonal antibody therapy REGEN-COV (casirivimab with imdevimab) reduced the risk of symptomatic COVID-19 in household contacts of people with SARS-CoV-2 by 81% in a phase 3 clinical trial conducted with the National Institute of Allergy and Infectious Diseases, Regeneron Pharmaceuticals…
The Food and Drug Administration and Centers for Disease Control and Prevention jointly recommended a pause in the use of Johnson & Johnson’s COVID-19 vaccine, following six reported cases of rare but severe types of blood clots following the vaccine’s administration.
AHA and the Health Information Sharing and Analysis Center (Health-ISAC), a non-profit member organization for sharing cyber threat intelligence and best practices, released a joint white paper to help senior health care leaders understand and respond to certain cyber risks to their enterprise…
As part of its recognition of Black Maternal Health Week (April 11-17), the Department of Health and Human Services through the Centers for Medicare & Medicaid Services approved a Section 1115 waiver for Illinois to be the first state to extend full Medicaid coverage to pregnant women for up to…
Reps. Terri Sewell, D-Ala., and Vern Buchanan, R-Fla., introduced The Resetting the Impact Act (TRIA) of 2021, AHA-supported legislation that takes into account unforeseen changes since the 2014 implementation of the Improving Medicare Post-Acute Care Transformation (IMPACT) Act to reflect 2021…
AHA’s Physician Alliance is holding a webinar April 15 at 2 p.m. ET to explore how understanding human factors can help leaders and clinical teams connect and advance patient safety together.
The Centers for Medicare & Medicaid Services will no longer waive certain requirements for long-term care and skilled nursing facilities beginning May 9 or 10, according to updated guidance released.
Pfizer said it is seeking an amended emergency use authorization for its COVID-19 vaccine, requesting that the Food and Drug Administration allow its use for individuals between 12 and 15 years old.
AHA voiced support for confirming Biden nominees Andrea Palm as deputy secretary of the Department of Health and Human Services and Chiquita Brooks-LaSure as administrator for the Centers for Medicare & Medicaid Services.
The Centers for Medicare & Medicaid Services has selected 61 applicants for the Value in Opioid Use Disorder Treatment Demonstration, a four-year Medicare payment model beginning this month for selected health care providers who agree to participate.